Word,Probability
late line,0.028046459871749516
low risk,0.023578292439880005
multiple myeloma,0.023578292439880005
autologous stem,0.01879000891611509
later line,0.013568923737444972
refractory myeloma,0.013568923737444972
patient population,0.013568923737444972
regulatory approval,0.013568923737444972
relevant dose,0.013568923737444972
clinical milestones,0.013568923737444972
